Starcef 100mg capsules
Dexa Medica
Ingredients in every capsule
| Cefixime | 100 mg |
Each package contains
5 strips of 6 capsules
Dosage form
 |
capsule |
Dosage formCapsule; hard
Flavour
None
W.H.O. classification
J01D
J01D
A.T.C. Level 1
Anatomical Main group
J - Antiinfectives for systemic use
J01D
A.T.C. Level 2
Therapeutic subgroup
J01 - Antibacterials for Systemic Use
J01D
A.T.C. Level 3
Pharmacological subgroup
J01D - Other Beta-Lactam Antibacterials in ATC
Available in
 |
Indonesia |
 |
Myanmar |
 |
Cambodia |
Warnings
Alcohol
CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.
Lactation
CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.
Indication
Treatment of infections caused by susceptible microorganisms, i.e.:
Urinary infections without complications
caused by Escherichia coli and Proteus mirabilis
Otitis media
caused by Haemophilus influenzae (ß-lactamase positive and negative strains), Moraxella (Branhamella) catarrhalis (most of which are ß-lactamase positive) and Streptococcus pyogenes.
Pharyngitis and tonsillitis
caused by Streptococcus pyogenes.
Acute bronchitis and acute exacerbation of chronic bronchitis
caused by Streptococcus pneumoniae and Haemophilus influenzae (ß-lactamase positive and negative strains).
Urinary infections without complications
caused by Escherichia coli and Proteus mirabilis
Otitis media
caused by Haemophilus influenzae (ß-lactamase positive and negative strains), Moraxella (Branhamella) catarrhalis (most of which are ß-lactamase positive) and Streptococcus pyogenes.
Pharyngitis and tonsillitis
caused by Streptococcus pyogenes.
Acute bronchitis and acute exacerbation of chronic bronchitis
caused by Streptococcus pneumoniae and Haemophilus influenzae (ß-lactamase positive and negative strains).
Dosage
0 TO 18 YEARS, WEIGHT < 30 KG
For adults and children weighing ≥30 kg, the usual daily dose is 50-100 mg (potency) of STARCEF® given orally twice a day. Dosage should be adjusted according to age, body weight, and condition of the patients.
For severe infections, the dosage may be increased up to 200 mg (potency), given twice a day.
PATIENTS WITH IMPAIRED RENAL FUNCTION
Patients with impaired renal function need a dosage adjustment depending on the degree of renal impairment. Recommended dosage: 75% of the standard dosage (i.e. 300 mg a day) if creatinine clearance is between 21 and 60 ml/minute or for patients on renal hemodialysis and 50% of the standard dosage (i.e. 200 mg a day) if creatinine clearance is <20 ml/minute or for patients on continuous ambulatory dialysis.
For adults and children weighing ≥30 kg, the usual daily dose is 50-100 mg (potency) of STARCEF® given orally twice a day. Dosage should be adjusted according to age, body weight, and condition of the patients.
For severe infections, the dosage may be increased up to 200 mg (potency), given twice a day.
PATIENTS WITH IMPAIRED RENAL FUNCTION
Patients with impaired renal function need a dosage adjustment depending on the degree of renal impairment. Recommended dosage: 75% of the standard dosage (i.e. 300 mg a day) if creatinine clearance is between 21 and 60 ml/minute or for patients on renal hemodialysis and 50% of the standard dosage (i.e. 200 mg a day) if creatinine clearance is <20 ml/minute or for patients on continuous ambulatory dialysis.